1 Unit of Semetiotics, Liver and Alcohol-related Disease, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Units of Semetiotics, Liver and Alcohol related disease, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
2 Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy. Electronic address: alessandro.vitale@unipd.it.
3 The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
4 Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
5 Northwestern Medicine, Chicago, IL, USA.
6 Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea.
7 Department of Surgery & Cancer, Imperial College London, London, UK; Division of Oncology, Department of Translational Medicine (DIMET), The University of Piemonte Orientale "A. Avogadro", Novara, Italy.
8 Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.